🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

European stocks rise; Tesla earnings boost global sentiment

Published 04/24/2024, 02:53 AM
Updated 04/24/2024, 03:09 AM
© Reuters
UK100
-
FCHI
-
DE40
-
MSFT
-
GOOGL
-
GC
-
LCO
-
CL
-
TSLA
-
META
-

Investing.com - European stock markets mostly rose Wednesday, largely maintaining the recent positive tone as the quarterly earnings season continues in full swing.

At 03:40 ET (08:40 GMT), the DAX index in Germany traded 0.2% higher, the FTSE 100 in the U.K. climbed 0.3%, while the CAC 40 in France traded 0.1% lower.

U.S. tech bounce boosts global sentiment 

European equities have benefited from the positive tone generated globally from an extended rebound in the U.S. technology sector, emphasised by strong gains from electric vehicle giant Tesla (NASDAQ:TSLA) after Tuesday’s close.

Tesla stock jumped in premarket trading even as the carmaker flagged accelerated plans to develop cheaper EV models, a key element in its elevated valuation, overshadowing disappointing earnings.

There are more earnings from the U.S. Big Tech sector to digest Wednesday, with Facebook-parent Meta Platforms (NASDAQ:META) due later, followed on Thursday by Microsoft (NASDAQ:MSFT) and Google-parent Alphabet (NASDAQ:GOOGL).

European earnings continue 

Back in Europe, there are also corporate results to digest.

Volvo (OTC:VLVLY) Car (ST:VOLCARb) stock fell over 7% after the Swedish automaker's operating earnings missed forecasts due to lower revenues and losses at its Polestar business, although the company predicted igood demand for its vehicles this year.

Orange (EPA:ORAN) stock fell 2% after the French telecommunications giant reported slower first-quarter revenue growth than expected after sales in its European unit, the company’s biggest business group outside of France, declined.

Roche (SIX:RO) stock rose 1.7% after the Swiss pharmaceutical company reported a modest uptick in first-quarter sales, even as waning demand for its Covid-19 products continued to weigh.

Sales were up 2% at constant exchange rates, led by stronger demand for Roche’s newer medicines and diagnostics, the company said, while, excluding Covid-19 products, sales were up 7%.

German Ifo to show improvement 

The main economic data release in Europe Wednesday will be Germany’s Ifo Institute’s survey on business conditions and expectations for April.

This is expected to show a small improvement in sentiment in Europe’s largest economy, although this is unlikely to stop the European Central Bank from cutting interest rates in June, as recently flagged by a number of ECB officials, including President Christine Lagarde.

Crude gains on U.S. stockpiles drop

Oil prices edged higher Wednesday, boosted by industry data showing a surprise drop in U.S. inventories, while the tensions in the MIddle East remain in focus.

By 02:05 ET, the U.S. crude futures traded 0.3% higher at $83.58 a barrel, while the Brent contract climbed 0.3% to $88.67 a barrel. 

U.S. crude inventories fell just over 3 million barrels in the week ended April 19, according to data from the American Petroleum Institute, released on Tuesday. A build of around 800,000 barrels had been expected.

Official data on crude stockpiles from the Energy Information Administration are due later Wednesday for confirmation.

Traders will also focus on the latest developments in the Middle East, with Israel heavily shelling parts of Gaza on Tuesday, though the impact on oil supplies remains limited for now.

Additionally, gold futures rose 0.2% to $2,338.65/oz, while EUR/USD traded 0.1% lower at 1.0694.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.